ASRT ASRT

Assertio Stock Price

2.27
0.12 (5.58%)
2.27
Volume 712
Bid Price 2.15
Ask Price 2.25
News -
Day High

Low
0.419

52 Week Range

High
3.06

Day Low
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Assertio Holdings Inc ASRT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.12 5.58% 2.27 08:40:11
Open Price Low Price High Price Close Price Prev Close
2.15
Trades Volume Avg Volume 52 Week Range
11 712 - 0.419 - 3.06
Last Trade Time Type Quantity Stock Price Currency
08:49:21 1 $ 2.15 USD

Period:

Draw Mode:

Assertio Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 101.32M 44.63M 44.47M $ 106.28M $ -8.06M -0.64 -2.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 1.40M 17.90%

more financials information »

Assertio News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ASRT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.682.682.092.25984,628-0.41-15.3%
1 Month2.103.061.822.471,240,2110.178.1%
3 Months1.033.061.00031.781,548,8801.24120.39%
6 Months1.313.060.85121.57968,1290.9673.28%
1 Year0.6383.060.4190.99096565,153,7031.63255.8%
3 Years4.155.760.331.062,886,928-1.88-45.3%
5 Years7.308.080.331.212,621,637-5.03-68.9%

Assertio Description

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
Your Recent History
NASDAQ
ASRT
Assertio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220120 14:26:45